Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA
- 18 February 2021
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (2), 513-518
- https://doi.org/10.1016/j.dsx.2021.02.022
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Mild or Moderate Covid-19The New England Journal of Medicine, 2020
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective AnalysisThe American Journal of Tropical Medicine and Hygiene, 2020
- Benefits of Metformin in Attenuating the Hallmarks of AgingCell Metabolism, 2020
- AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting GlycolysisThe Journal of Immunology, 2020
- AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Metformin and ageing: improving ageing outcomes beyond glycaemic controlDiabetologia, 2017
- Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic DurationJournal of Diabetes Research, 2017
- Metformin as a Tool to Target AgingCell Metabolism, 2016
- Systematic Review of Comorbidity Indices for Administrative DataMedical Care, 2012